Psoriasis, comorbidities, therapy and its adverse effects

• Autor(a) principal: Axer, Mariana Oliveira
• Data de Publicação: 2023
• Outros Autores: Cunha, Thaís Carvalho, Barbosa, Leandra Covre, Peron, Nathânia Aparecida Luna, Dias, Ana Luiza Scussulim Florindo Alcure
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Revista Brasileira de Educação e Saúde
• Texto Completo: https://www.gvaa.com.br/revista/index.php/REBES/article/view/10125

Psoriasis is a chronic inflammatory skin disease that affects 2-3% of the population worldwide, is characterized by erythematous scaly plaques and can involve the joints in the case of arthropathic psoriasis and is associated with significant impairments in physical and mental health due to its impact on daily activities. Objectives: To discuss the comorbidities and treatment of psoriasis and its adverse effects. Methodology: This is a literature review with a qualitative descriptive approach. The search for material took place in September 2023, using the SciELO and PubMed databases. For the search, the following terms (keywords and delimiters) will be used in combination with the "AND" connective, using the following descriptors: "Psoriasis"; "Comorbidity"; "Treatment". Results: Studies have shown that patients with psoriasis have increased hyperlipidemia, hypertension, coronary artery disease, type 2 diabetes and increased body mass index. Therapeutic options for psoriasis include topical therapy, phototherapy or systemic treatment. Mild to moderate psoriasis, for example, can be treated topically with a combination of therapies, while moderate to severe psoriasis usually requires systemic treatment; and the presence of comorbidities such as psoriatic arthritis is also highly relevant in treatment management. Advances in diagnosis and treatment have resulted in a growing number of therapeutic options that can dramatically improve the lives of people with psoriasis. However, the disease is still very common, and treatment and access do not yet meet patients' needs.